Stimulating the 5-HT2C receptor alone does not appear to cause hallucinations or heart valvular problems.

FORBES: Why Does Arena's Obesity Drug Have Abuse Potential?

Non-valvular atrial fibrillation refers to atrial fibrillation in patients who do not have significant problems in their heart valves.

FORBES: FDA Approves Xarelto

Belviq has not been studied in patients with serious valvular heart disease.

FORBES: Arena Obesity Drug Approval Looks Like Best-Case Scenario

The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto rivaroxaban to reduce the risk of stroke in people who have abnormal heart rhythm non-valvular atrial fibrillation.

FORBES: FDA Approves Xarelto

Xarelto is already FDA-approved to reduce the risk of DVTs and PEs from occurring after knee or hip replacement surgery (July 2011), and to reduce the risk of stroke in people who have a type of abnormal heart rhythm called non-valvular atrial fibrillation (November 2011).

FORBES: Rivaroxaban Gains FDA Indications For The Treatment And Prevention Of DVT And PE

In England, Scotland and Wales, patients with angina, valvular heart disease, a heart murmur or heart failure do not have to tell the Driver and Vehicle Licensing Agency (DVLA) and can continue to drive a car a month after an episode as long as their doctor says they are fit to.

BBC: Car seat with heart monitor could prove a life-saver